Boston News Latest Update - Angiotech and Boston Scientific welcome journal article noting important differences between drug-eluting stent brands (PR Newswire via Yahoo! Finance)

Angiotech Pharmaceuticals, Inc. today announced its corporate partner, Boston Scientific Corporation, has welcomed the publication of an article in the current edition of the Journal of the American College of Cardiology reviewing data on more than 19,000 patients from the Swedish national registry who were evaluated for restenosis, or the re-narrowing or arteries after percutaneous coronary ...


Click Here to read the entire article...